HOOKIPA Pharma Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| HOOKIPA Pharma Inc. | HOOK - NASDAQ |
$14.00-$16.00 | $14.00 | $14.30 | 6 million | 4/18/2019 |
| BofA Merrill Lynch, SVB Leerink , RBC Capital | ||||||
Co-Manager(s): Kempen | ||||||
| Health Care | ||||||
Filing(s): Filed 2019-03-22 Terms Added 2019-04-08 | ||||||
HOOKIPA Pharma Inc. Quote & Chart - Click for current quote - HOOK
IPO Boutique aggregates information on public companies and private companies, such as "HOOK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About HOOKIPA Pharma Inc. (adapted from HOOKIPA Pharma Inc. prospectus):
They are a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on our proprietary arenavirus platform that is designed to reprogram the body's immune system.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on our proprietary arenavirus platform that is designed to reprogram the body's immune system.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "HOOK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.